CPA
TMDX icon

Capital Performance Advisors’s Transmedics TMDX Stock Holding History

Capital Performance Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4
Closed -$628 – 2453
2024
Q3 		$628 Buy
+4
New +$616 ﹤0.01% 2144

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Performance Advisors's TMDX Position: Q4 2024 in Review

Capital Performance Advisors sold out of Transmedics (TMDX) in Q4 2024, closing a stake of 4 shares — an estimated $628 sold.

Capital Performance Advisors first reported a position in TMDX in Q3 2024 and held it in 1 quarter. The position peaked at $628 in Q3 2024. 315 funds tracked by Wall St. Rank hold TMDX as of Q4 2024.

  • Capital Performance Advisors reported no remaining Transmedics position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 4 Transmedics shares in Q4 2024, an estimated $628.
  • Capital Performance Advisors first reported a position in Transmedics in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Transmedics position peaked at $628 in Q3 2024.
  • 315 funds tracked by Wall St. Rank held Transmedics as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.